肺动脉高压:从全球视野到国内现状  

Pulmonary Hypertension:From a Global Perspective to the Domestic Situation

作　　者：柳志红 段安琪 罗勤 LIU Zhihong;DUAN Anqi;LUO Qin(Center for Respiratory and Pulmonary Vascular Diseases,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China)

机构地区：[1]中国医学科学院、北京协和医学院、国家心血管病中心、阜外医院、呼吸与肺血管疾病诊治中心,北京100037

出　　处：《心血管病学进展》2024年第1期1-2,共2页Advances in Cardiovascular Diseases

摘　　要：肺动脉高压是一种异常的血流动力学状态,其病因复杂,进展迅速,对人类的生命健康造成了严重威胁,成为一项全球性的健康难题。肺动脉高压需根据血流动力学确诊,并进一步临床分类,多学科综合管理对于肺动脉高压的诊疗至关重要。近年来,中国在肺动脉高压领域取得了显著进展,但仍面临着诊疗规范性欠佳、医疗资源分配不均、专业医学培训不足等挑战。肺动脉高压诊疗规范性文件的发布有望提高基层医疗水平,为患者提供更全面及优质的医疗服务,从而改善患者的生存环境和生活质量。Pulmonary hypertension(PH)is an abnormal hemodynamic state,with a complex etiology and rapid progression,posing a serious threat to human life and health,and becoming a global health problem.PH needs to be diagnosed based on hemodynamics and further classified clinically.Multidisciplinary comprehensive management is crucial for the diagnosis and treatment of PH.In recent years,China has made significant progress in the field of PH,but still faces challenges such as poor diagnostic and treatment standards,uneven distribution of medical resources,and insufficient professional medical training.The release of regulatory documents for PH diagnosis and treatment is expected to enhance primary healthcare capabilities,providing more comprehensive and high-quality medical services for patients,thereby improving their living environment and quality of life.

关 键 词：肺动脉高压 右心导管检查 肺血管病 

分 类 号：R544.1[医药卫生—心血管疾病]